|
1
|
Zhu C, Bassig BA, Zaridze D, Boyle P, Dai
M, Li Q and Zheng T: A birth cohort analysis of the incidence of
ascending and descending colon cancer in the United States,
1973-2008. Cancer Causes Control. 24:1147–1156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Printz C: New findings in colon cancer
incidence, screening. Cancer. 120:2224–2225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X, Yan D, Teng M, Fan J, Zhou C, Li
D, Qiu G, Sun X, Li T, Xing T, et al: Reduced expression of PER3 is
associated with incidence and development of colon cancer. Ann Surg
Oncol. 19:3081–3088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uzgare RP, Sheets TP and Johnston DS:
Evaluation of melphalan, oxaliplatin, and paclitaxel in colon,
liver, and gastric cancer cell lines in a short-term exposure model
of chemosaturation therapy by percutaneous hepatic perfusion.
Anticancer Res. 33:1989–2000. 2013.PubMed/NCBI
|
|
5
|
Leone F, Artale S, Marino D, Cagnazzo C,
Cascinu S, Pinto C, Fornarini G, Tampellini M, Di Fabio F,
Sartore-Bianchi A, et al: Panitumumab in combination with
infusional oxaliplatin and oral capecitabine for conversion therapy
in patients with colon cancer and advanced liver metastases. The
MetaPan study. Cancer. 119:3429–3435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mettu NB, Hurwitz H and Hsu DS: Use of
molecular biomarkers to inform adjuvant therapy for colon cancer.
Oncology (Williston Park). 27:746–754. 2013.PubMed/NCBI
|
|
7
|
Kannen V, Garcia SB, Stopper H and
Waaga-Gasser AM: Glucagon-like peptide 2 in colon carcinogenesis:
Possible target for anti-cancer therapy? Pharmacol Ther. 139:87–94.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anderson E, Devenney PS, Hill RE and
Lettice LA: Mapping the Shh long-range regulatory domain.
Development. 141:3934–3943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwong L, Bijlsma MF and Roelink H:
Shh-mediated degradation of Hhip allows cell autonomous and
non-cell autonomous Shh signalling. Nat Commun. 5:48492014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Filbin MG, Dabral SK, Pazyra-Murphy MF,
Ramkissoon S, Kung AL, Pak E, Chung J, Theisen MA, Sun Y,
Franchetti Y, et al: Coordinate activation of Shh and PI3K
signaling in PTEN-deficient glioblastoma: New therapeutic
opportunities. Nat Med. 19:1518–1523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song L and Liu Y, Yu Y, Duan X, Qi S and
Liu Y: Shh signaling guides spatial pathfinding of raphespinal
tract axons by multidirectional repulsion. Cell Res. 22:697–716.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morton JP and Lewis BC: Shh signaling and
pancreatic cancer: Implications for therapy? Cell Cycle.
6:1553–1557. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vorechovský I, Benediktsson KP and
Toftgård R: The patched/hedgehog/smoothened signalling pathway in
human breast cancer: No evidence for H133 Y SHH PTCH and SMO
mutations. Eur J Cancer. 35:711–713. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du P, Ye L, Li H, Yang Y and Jiang WG: The
tumour suppressive role of metastasis suppressor-1, MTSS1, in human
kidney cancer, a possible connection with the SHH pathway. J Exp
Ther Oncol. 10:91–99. 2012.PubMed/NCBI
|
|
15
|
Li X, Wang Z, Ma Q, Xu Q, Liu H, Duan W,
Lei J, Ma J, Wang X, Lv S, et al: Sonic hedgehog paracrine
signaling activates stromal cells to promote perineural invasion in
pancreatic cancer. Clin Cancer Res. 20:4326–4338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu X, Su B, Xie C, Wei S, Zhou Y, Liu H,
Dai W, Cheng P, Wang F, Xu X and Guo C: Sonic hedgehog-Gli1
signaling pathway regulates the epithelial mesenchymal transition
(EMT) by mediating a new target gene, S100A4, in pancreatic cancer
cells. PLoS One. 9:e964412014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Omenetti A and Diehl AM: The adventures of
sonic hedgehog in development and repair. II. Sonic hedgehog and
liver development, inflammation and cancer. Am J Physiol
Gastrointest Liver Physiol. 294:G595–G598. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshikawa K, Shimada M, Miyamoto H,
Higashijima J, Miyatani T, Nishioka M, Kurita N, Iwata T and Uehara
H: Sonic hedgehog relates to colorectal carcinogenesis. J
Gastroenterol. 44:1113–1117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mazumdar T, DeVecchio J, Agyeman A, Shi T
and Houghton JA: The GLI genes as the molecular switch in
disrupting Hedgehog signaling in colon cancer. Oncotarget.
2:638–645. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pricl S, Cortelazzi B, Dal Col V, Marson
D, Laurini E, Fermeglia M, Licitra L, Pilotti S, Bossi P and
Perrone F: Smoothened (SMO) receptor mutations dictate resistance
to vismodegib in basal cell carcinoma. Mol Oncol. 9:389–397. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Kane GM, Lyons T, McDonald I, Mulligan
N, Moloney FJ, Murray D and Kelly CM: Vismodegib in the treatment
of advanced BCC. Ir Med J. 107:215–216. 2014.PubMed/NCBI
|
|
23
|
Petry FR, Nicholls SB, Hébert SS and
Planel E: A simple method to avoid nonspecific signal when using
monoclonal anti-tau antibodies in western blotting of mouse brain
proteins. Methods Mol Biol. 1523:263–272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hockenbery DM, Zutter M, Hickey W, Nahm M
and Korsmeyer SJ: BCL2 protein is topographically restricted in
tissues characterized by apoptotic cell death. Proc Natl Acad Sci
USA. 88:6961–6965. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee EY, Ji H, Ouyang Z, Zhou B, Ma W,
Vokes SA, McMahon AP, Wong WH and Scott MP: Hedgehog
pathway-regulated gene networks in cerebellum development and
tumorigenesis. Proc Natl Acad Sci USA. 107:9736–9741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chinnaiya K, Tickle C and Towers M: Sonic
hedgehog-expressing cells in the developing limb measure time by an
intrinsic cell cycle clock. Nat Commun. 5:42302014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tickle C and Barker H: The sonic hedgehog
gradient in the developing limb. Wiley Interdiscip Rev Dev Biol.
2:275–290. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang B, Harrison W, Overbeek PA and Zheng
H: Transposon mutagenesis with coat color genotyping identifies an
essential role for Skor2 in sonic hedgehog signaling and cerebellum
development. Development. 138:4487–4497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dessinioti C, Plaka M and Stratigos AJ:
Vismodegib for the treatment of basal cell carcinoma: Results and
implications of the ERIVANCE BCC trial. Future Oncol. 10:927–936.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berrada N, Lkhoyali S, Mrabti H and
Errihani H: Vismodegib: The proof of concept in Basal cell
carcinoma. Clin Med Insights Oncol. 8:77–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lyons TG, O'Kane GM and Kelly CM: Efficacy
and safety of vismodegib: A new therapeutic agent in the treatment
of basal cell carcinoma. Expert Opin Drug Saf. 13:1125–1132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK,
Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes
metastasis and lymphangiogenesis via activation of Akt, EMT, and
MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan HX, Wang S, Zhao H, Liu N, Chen D, Sun
M and Zheng JH: Sonic hedgehog signaling may promote invasion and
metastasis of oral squamous cell carcinoma by activating MMP-9 and
E-cadherin expression. Med Oncol. 31:412014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Das S, Samant RS and Shevde LA: The
hedgehog pathway conditions the bone microenvironment for
osteolytic metastasis of breast cancer. Int J Breast Cancer.
2012:2986232012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Varnat F, Duquet A, Malerba M, Zbinden M,
Mas C, Gervaz P and i Altaba A Ruiz: Human colon cancer epithelial
cells harbour active HEDGEHOG-GLI signalling that is essential for
tumour growth, recurrence, metastasis and stem cell survival and
expansion. EMBO Mol Med. 1:338–351. 2009. View Article : Google Scholar : PubMed/NCBI
|
